These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 11185394)

  • 1. Neuroscience. An antibiotic to treat Alzheimer's?
    Helmuth L
    Science; 2000 Nov; 290(5495):1273-4. PubMed ID: 11185394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. '...and C is for Clioquinol' - the AbetaCs of Alzheimer's disease.
    Melov S
    Trends Neurosci; 2002 Mar; 25(3):121-3; discussion 123-4. PubMed ID: 11852134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapeutic effect of clioquinol for Alzheimer disease].
    Iwata N
    Nihon Yakurigaku Zasshi; 2008 Mar; 131(3):223. PubMed ID: 18421848
    [No Abstract]   [Full Text] [Related]  

  • 4. Metal chelator decreases Alzheimer beta-amyloid plaques.
    Gouras GK; Beal MF
    Neuron; 2001 Jun; 30(3):641-2. PubMed ID: 11430794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clioquinol reduces zinc accumulation in neuritic plaques and inhibits the amyloidogenic pathway in AβPP/PS1 transgenic mouse brain.
    Wang T; Wang CY; Shan ZY; Teng WP; Wang ZY
    J Alzheimers Dis; 2012; 29(3):549-59. PubMed ID: 22269164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice.
    Cherny RA; Atwood CS; Xilinas ME; Gray DN; Jones WD; McLean CA; Barnham KJ; Volitakis I; Fraser FW; Kim Y; Huang X; Goldstein LE; Moir RD; Lim JT; Beyreuther K; Zheng H; Tanzi RE; Masters CL; Bush AI
    Neuron; 2001 Jun; 30(3):665-76. PubMed ID: 11430801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metal complexing agents as therapies for Alzheimer's disease.
    Bush AI
    Neurobiol Aging; 2002; 23(6):1031-8. PubMed ID: 12470799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alzheimer's disease: Mental plaque removal.
    De Strooper B; Woodgett J
    Nature; 2003 May; 423(6938):392-3. PubMed ID: 12761533
    [No Abstract]   [Full Text] [Related]  

  • 9. Current status of metals as therapeutic targets in Alzheimer's disease.
    Finefrock AE; Bush AI; Doraiswamy PM
    J Am Geriatr Soc; 2003 Aug; 51(8):1143-8. PubMed ID: 12890080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Copper and clioquinol treatment in young APP transgenic and wild-type mice: effects on life expectancy, body weight, and metal-ion levels.
    Schäfer S; Pajonk FG; Multhaup G; Bayer TA
    J Mol Med (Berl); 2007 Apr; 85(4):405-13. PubMed ID: 17211610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic treatments for Alzheimer's disease based on metal bioavailability.
    Crouch PJ; Barnham KJ; Bush AI; White AR
    Drug News Perspect; 2006 Oct; 19(8):469-74. PubMed ID: 17160147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of amyloid formation: a strategy to delay the onset of Alzheimer's disease.
    Lansbury PT
    Curr Opin Chem Biol; 1997 Aug; 1(2):260-7. PubMed ID: 9667848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutual stimulation of beta-amyloid fibrillogenesis by clioquinol and divalent metals.
    Bolognin S; Zatta P; Drago D; Tognon G; Parnigotto PP; Ricchelli F
    Neuromolecular Med; 2008; 10(4):322-32. PubMed ID: 18712494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amyloidogenesis induced by diet cholesterol and copper in a model mouse for Alzheimer's disease and protection effects of zinc and fluvastatin.
    Yao D; Jing T; Niu L; Huang X; Wang Y; Deng X; Wang M
    Brain Res Bull; 2018 Oct; 143():1-8. PubMed ID: 30227236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Copper and Alzheimer's Disease.
    Mathys ZK; White AR
    Adv Neurobiol; 2017; 18():199-216. PubMed ID: 28889269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of metals in modulating metalloprotease activity in the AD brain.
    Filiz G; Price KA; Caragounis A; Du T; Crouch PJ; White AR
    Eur Biophys J; 2008 Mar; 37(3):315-21. PubMed ID: 18270696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clioquinol decreases amyloid-beta burden and reduces working memory impairment in a transgenic mouse model of Alzheimer's disease.
    Grossi C; Francese S; Casini A; Rosi MC; Luccarini I; Fiorentini A; Gabbiani C; Messori L; Moneti G; Casamenti F
    J Alzheimers Dis; 2009; 17(2):423-40. PubMed ID: 19363260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alzheimer's disease, metal ions and metal homeostatic therapy.
    Zatta P; Drago D; Bolognin S; Sensi SL
    Trends Pharmacol Sci; 2009 Jul; 30(7):346-55. PubMed ID: 19540003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metal-protein attenuating compounds and Alzheimer's disease.
    Ritchie CW; Bush AI; Masters CL
    Expert Opin Investig Drugs; 2004 Dec; 13(12):1585-92. PubMed ID: 15566316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clioquinol, a drug for Alzheimer's disease specifically interfering with brain metal metabolism: structural characterization of its zinc(II) and copper(II) complexes.
    Di Vaira M; Bazzicalupi C; Orioli P; Messori L; Bruni B; Zatta P
    Inorg Chem; 2004 Jun; 43(13):3795-7. PubMed ID: 15206857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.